Shots: Apple and Google have released their smartphone technology to automatically notify people if they have been exposed to the COVID-19. Last month, the companies collaborated to leverage their technology […]readmore
Tags : Launch
Shots: Shots: The companies collaborated to launch pilot program integrating OneTouch Reveal app with Noom’s digital diabetes and weight loss management program Through this program, patients using the OneTouch Reveal […]readmore
Shots: COVID Advocacy Exchange is a virtual platform targeted to unite patient advocacy organizations, patients, policy makers, healthcare practitioners and industry in the exchange of information and will also provide […]readmore
Shots: Shots: Teva and Celltrion launch Truxima (rituximab-abbs) to treat RA in combination with MTX in patients with mod.to sev. active RA who have an inadequate response to one or […]readmore
Shots: The companies have launched Fulphila, a biosimilar referencing Neulasta (pegfilgrastim) and is approved by Health Canada to decrease the incidence of infection, as manifested by febrile neutropenia, in patients […]readmore
Shots: The companies launched Fulphila, a biosimilar referencing Neulasta (pegfilgrastim) in Australia. The biosimilar received TGA’s approval to treat cancer patients following the CT, to decrease the duration of neutropenia […]readmore
Shots: Merck, Pfizer and Eli Lilly announced a program enabling employees with medical and laboratory expertise to aid in the fight against COVID-19 while maintaining their base pay Merck will […]readmore
Shots: BioMedomic develops and manufactures the POC tests that will be available through BD and distributed exclusively by Henry Schein to the HCPs in the US The POC test detects […]readmore
Shots: Celltrion completes its first step of developing an antiviral treatment against COVID-19 and aims to launch a rapid self-testing diagnostic kit, that has the potential of providing results within […]readmore
Shots: From Mar 16, 2020, the Californians availed an online COVID-19 screener survey and till date, the site has run out of appointments. The people who met the eligibility criteria […]readmore